Described here is a simple method for the purification of a gene product in Streptococcus mutans. This technique may be advantageous in the purification of proteins, especially membrane proteins and high molecular mass proteins, and can be used with various other bacterial species.
Elucidation of a gene's function typically involves comparison of phenotypic traits of wild-type strains and strains in which the gene of interest has been disrupted. Loss of function following gene disruption is subsequently restored by exogenous addition of the product of the disrupted gene. This helps to determine the function of the gene. A method previously described involves generating a gtfC gene-disrupted Streptococcus mutans strain. Here, an undemanding method is described for purifying the gtfC gene product from the newly generated S. mutans strain following the gene disruption. It involves the addition of a polyhistidine-coding sequence at the 3′ end of the gene of interest, which allows simple purification of the gene product using immobilized metal affinity chromatography. No enzymatic reactions other than PCR are required for the genetic modification in this method. The restoration of the gene product by exogenous addition after gene disruption is an efficient method for determining gene function, which may also be adapted to different species.
Analysis of a gene's function usually involves comparison of phenotypic traits of wild-type strains to strains in which the gene of interest has been disrupted.Once the gene-disrupted strain is produced, exogenous addition of the gene product allows functional restoration.
The most common method for obtaining purified gene products required for subsequent restoration assays is by performing heterologous expression in Escherichia coli1. However, the expression of membrane proteins or high molecular mass proteins is often difficult using this system1. In these cases, the target protein is usually isolated from the cells that natively synthesizes the protein through a complex series of steps, which may lead to loss of the gene product. To overcome these issues, a simple procedure has been developed for gene product purification following a gene disruption method2, PCR-based DNA splicing method3 (designated two-step fusion PCR), and electroporation for genetic transformation in Streptococcus mutans. Addition of a polyhistidine tag (His-tag) to the C-terminus of the gene product facilitates its purification by immobilized metal affinity chromatography (IMAC).
To isolate the His-tag-expressing strain, the entire genomic DNA of the gene of interest (in this His-tag-expressing gene-disrupted strain) is replaced with an antibiotic-resistant marker gene. The procedure for generating the His-tag-expressing strainis nearly identical to that for generating a gene-disrupted strain as described previously4,5. Therefore, the methods for gene disruption and gene product isolation should be performed as serial experiments for the functional analysis.
In the present work, a polyhistidine-coding sequence is attached to the 3′ end of the gtfC (GenBank locus tag SMU_1005) gene, encoding glucosyltransferase-SI (GTF-SI) in S. mutans6. Then, expression studies in a streptococcal species were performed. Achieving heterologous gtfC expression by E. coli is difficult, likely because of the high molecular mass of GTF-SI. This strain is named S. mutans His-gtfC. A schematic illustration depicting the organization of the gtfC and spectinomycin resistance gene cassette (spcr)7 loci in wild-type S. mutans (S. mutans WT) and its derivatives is shown in Figure 1. The GTF-SI is a secretory protein that contributes to the development of cariogenic dental biofilm6. Under the presence of sucrose, an adherent biofilm is observed on a smooth glass surface in WT S. mutans strain but not in the S. mutans gtfC-disrupted strain (S. mutans ΔgtfC)2,5. Biofilm formation is restored in S. mutans ΔgtfC upon exogenous addition of the recombinant GTF-SI. The strain, S. mutans His-gtfC, is then used to produce the recombinant GTF-SI.
NOTE: Generation of S. mutans ∆gtfC, in which the entire coding region of the gtfC gene is replaced with spcr, must be completed prior to performing these protocols. Refer to the published article for details on generation5.
1. Primer design
2. Genomic DNA Extraction from S. mutans
NOTE: Each S. mutans strain should be cultured in brain heart infusion (BHI) medium at 37 °C under anaerobic conditions. The mutant strains of S. mutans ∆gtfC and S. mutans His-gtfC are cultured in BHI supplemented with 100 µg/mL spectinomycin.
3. PCR Amplification
NOTE: Table 1, Table 2, and Table 3 summarize the PCR primers, reagents, and amplification cycles, respectively.
4. Cell Transformation
5. Verification of Genome Recombination and Storage
6. Purification of Polyhistidine-tagged GTF-SI
7. Functional Restoration by Recombinant GTF-SI
Figure 3 shows the size of each amplicon from the first PCR (Figure 3A) and second PCR (Figure 3B). The size of each amplicon corresponded with the predicted size, as described in Table 1. Figure 4A shows S. mutans colonies transformed with the second PCR product and plated on the BHI agar plates containing spectinomycin. Colony PCR products were then run on the agarose gel (Figure 4B). Each amplicon was of the predicted size, as described in Table 1. Figure 5 shows images of SDS-PAGE and western blot. Protein purified with IMAC was observed as a single band by SDS-PAGE (Figure 5A). Western blot was performed using the anti-polyhistidine antibody to confirm that the observed band was the expected polyhistidine-tagged protein (Figure 5B) of 160 kDa. Figure 6 shows the sucrose-derived biofilm-forming ability of each S. mutans strain. Only S. mutans WT and S. mutans His-gtfC could form an adherent biofilm on the tube wall in the presence of 1% sucrose. This was not observed in S. mutans ΔgtfC (Figure 6A). However, the addition of the recombinant GTF-SI restored the adherent biofilm formation ability in S. mutans ΔgtfC (Figure 6B).
Figure 1: Organization of gtfC and spcr loci in the S. mutans UA159 genome and its derivatives. A schematic illustration of the His-tag between gtfC and spcr. The lengths of the genes and gaps are not to scale. Shaded pentagon: SMU_1004; solid pentagon: SMU_1006. This figure has been modified from a previous publication2. Please click here to view a larger version of this figure.
Figure 2: Strategy for two-step fusion PCR. A schematic illustration of S. mutans His-gtfC construction. The lengths of the genes and gaps are not to scale. The primer-binding sites in the template are indicated by patterns. (A) The regions harboring part of the gtfC gene in the S. mutans WT genome and harboring spcr in the S. mutans ΔgtfC genome were amplified using the first PCR. (B) The second PCR was performed with nested primers using the two fragments that were amplified by the first PCR as templates, and a DNA construct for homologous recombination was obtained. (C) The mutant strain was generated upon homologous recombination in the bacteria. This figure has been modified from a previous publication2. Please click here to view a larger version of this figure.
Figure 3: Agarose gel electrophoresis of first and second PCR products. (A) Products of the first PCR of a part of gtfC (gtfC; left image) and the region harboring spcr (spcr; right image) are shown. The single electrophoretic image is divided to label the marker bands. (B) The second PCR products amplified with the nested primers are shown. Each arrowhead indicates the predicted size of each PCR product. M = molecular marker. Please click here to view a larger version of this figure.
Figure 4: Colony PCR to screen generation of S. mutans His-gtfC. (A) S. mutans colonies transformed by the second PCR product are shown. Colony ID is indicated by circled numbers. (B) Agarose gel electrophoresis of the colony PCR products is shown. Circled lane number corresponds to the colony ID in Figure 4A. M = molecular marker. Please click here to view a larger version of this figure.
Figure 5: Confirmation of polyhistidine-tagged GTF-SI purification. (A) Representative SDS-PAGE image is shown. (B) Representative western blot image is shown. A nitrocellulose membrane on which GTF-SI was transferred was probed with a horseradish peroxidase-conjugated anti-polyhistidine monoclonal antibody. Immunoreactive bands were visualized using a chemiluminescence reaction. The arrowheads indicate the predicted size of the recombinant GTF-SI. M: molecular marker; 1 = sample prior to IMAC; 2 = sample obtained by IMAC. Please click here to view a larger version of this figure.
Figure 6: Functional restoration by addition of the recombinant GTF-SI. (A) The ability of sucrose-derived adherent biofilm formation is shown for each S. mutans strain. (B) The ability of forming adherent biofilms was restored in S. mutans ΔgtfC by addition of recombinant GTF-SI (25 µg). WT = S. mutans WT; ΔgtfC = S. mutans ΔgtfC; His-gtfC = S. mutans His-gtfC. Please click here to view a larger version of this figure.
Primer pairs | Sequence (5′ to 3′) | Expected band size (bp) | ||
1st PCR | ||||
gtfC-forward gtfC-reverse A,B |
TAAAGGTTATGTTTATTATTCAACGAGTGGTAACC ATGATGATGATGATGACTACCACCACCTCCAAATCTAAAGAAATTGTCAA |
1,090 | ||
spcr-forward A,C spcr-reverse |
GGTGGTAGTCATCATCATCATCATCATTAAATCGATTTTCGTTCGTGAAT TTAAGAGCAAGTTTAAGATAGAACATGTTACTCAC |
2,232 | ||
2nd PCR | ||||
Nested-forward Nested-reverse |
TGGTATTATTTCGATAATAACGGTTATATGGTCAC GCCATACTTAGAGAAATTTCTTTGCTAAATTCTTG |
3,179 | ||
Verification of recombination | ||||
Colony PCR | ||||
gtfC-forward Colony-reverse |
TAAAGGTTATGTTTATTATTCAACGAGTGGTAACC CCACTCTCAACTCCTGATCCAAACATGTAAGTACC |
1,482 | ||
Final verification | ||||
Up-forward Down-reverse |
TACGGCCGTATCAGTTATTACGATGCTAACTCTGG TTGTCCACTTTGAAGTCAACGTCTTGCAAGGCATG |
6,173 |
Table 1: Primers used in the protocol. AThe underlined sequences of 'gtfC-reverse and spcr-forward' are complementary, and the bold-typed sequencescode for the His-tag (gtfC-reverse; ATGATGATGATGATG, spcr-forward; CATCATCATCATCATCAT) and GS linker (gtfC-reverse; ACTACCACCACCTCC, spcr-forward; GGTGGTAGT). BThe DNA stop codon of gtfC has been removed. CA DNA stop codon (TAA) has been added immediately after the polyhistidine-coding sequences.
Reagent | Concentration of stock solution | Volume | Final concentration |
DNA polymerase premix | 2x | 25 μL | 1x |
Forward primer | 5 µM | 2 μL | 0.2 µM |
Reverse primer | 5 µM | 2 μL | 0.2 µM |
Template DNA | Variable | Variable | Variable |
Deionized water | – | Up to 50 μL | – |
Table 2: PCR reagents: For the first PCR, 2 µL of the DNA template was added. For the second PCR, 0.5-2 µL of first PCR amplicon was added to the reaction mixture. For colony PCR, bacterial cells were directly added to the reaction mixture.
Step | Temperature | Time | Number of cycles |
Initial denaturation | 98 °C | 2 min | 1 |
Denaturation Annealing Extension |
98 °C 50 °C 72 °C |
10 s 5 s Amplicon-dependent (1 min/1 kbp) |
35 |
Final extension | 72 °C | Amplicon-dependent (1 min/1 kbp) |
1 |
Table 3: PCR amplification cycles.
The design of primers is the most critical step in the protocol. The sequences of the gtfC-reverse and spcr-forward primers were automatically determined based on the sequences of both the 3′ end region of gtfC and the 5′ end region of spcr. Each primer includes 24 complementary bases that encode a GS linker and a His-tag-coding sequence at their 5' regions. Disruption of the native regulatory sequences located in the upstream flanking regions can be avoided by the addition of His-tag-coding sequences to the 3′ end. The DNA stop codon must be removed from the gtfC-reverse primer and added to the spcr-forward primer. Moreover, the gtfC-forward and spcr-reverse should be designed to amplify flanking regions of approximately 1 kb upstream and downstream of the target region of homologous recombination in the S. mutans WT genome, respectively. Addition of long flanking sequences improves the efficiency of homologous recombination. The nested primers were designed to be used instead of the outermost primer pair (gtfC-forward and spcr-reverse) in this protocol. Inclusion of nested primers is required for the second PCR, as detailed elsewhere5.
Transformation by electroporation is efficient1 and procedures for competent cell preparation preceding electroporation are also much simpler compared to the alternative methods16,17,18, although an electroporation apparatus is required. It is strongly recommended to prepare competent S. mutans WT anew in case of missing colonies on the plate after electroporation. Although incubation for a couple of hours after electroporation may improve transformation efficiency, the extra incubation does not affect success of the transformation. Cells in the log growth phase should be used for the competent cell preparation, as described previously5.
Since the amount of recombinant protein depends on the native expression of the gene, scale-up culture may be required in cases of proteins with lower expression.The method presented here is limited by the application of the functional restoration assay. The addition of gene of interest cannot be applied to intracellular proteins exogenously. However, the developed method presents considerable advantages in terms of facility, efficiency, and cost (e.g., no enzymatic reactions other than PCR) when working with the extracellular target protein. Additionally, the purification of the recombinant protein and confirmation of actual gene expression can be performed simply using common His-tag applications, as shown in Figure 5.
The present method, including gene disruption and gene product isolation, may be adapted for future use in other species as serial experiments for the functional analysis of a gene of interest.
The authors have nothing to disclose.
This work was supported by the Japan Society for the Promotion of Science (JSPS) (grant numbers 16K15860 and 19K10471 to T. M., 17K12032 to M. I., and 18K09926 to N. H.) and the SECOM Science and Technology Foundation (SECOM) (grant number 2018.09.10 No. 1).
Agarose | Nippon Genetics | NE-AG02 | For agarose gel electrophoresis |
Anaeropack | Mitsubishi Gas Chemical | A-03 | Anaerobic culture system |
Anti-His-Tag monoclonal antibody | MBL | D291-7 | HRP-conjugated |
BCA protein assay kit | Thermo Fisher Scientific | 23227 | Measurement of protein concentration |
Brain heart infusion broth | Becton, Dickinson | 237500 | Bacterial culture medium |
CBB R-250 | Wako | 031-17922 | For biofilm staining |
Centrifugal ultrafiltration unit | Sartorius | VS2032 | Buffer replacement and protein concentration |
Centrifuge | Kubota | 7780II | |
Chromatographic column | Bio-Rad | 7321010 | For IMAC |
Dialysis membrane clamp | Fisher brand | 21-153-100 | |
Dialysis tubing | As One | 2-316-06 | |
DNA polymerase | Takara | R045A | High-fidelity DNA polymerase |
DNA sequencing | Eurofins Genomics | ||
ECL substrate | Bio-Rad | 170-5060 | For western blotting |
EDTA (0.5 M pH 8.0) | Wako | 311-90075 | Tris-EDTA buffer preparation |
Electroporation cuvette | Bio-Rad | 1652086 | 0.2 cm gap |
Electroporator | Bio-Rad | 1652100 | |
EtBr solution | Nippon Gene | 315-90051 | For agarose gel electrophoresis |
Gel band cutter | Nippon Genetics | FG-830 | |
Gel extraction kit | Nippon Genetics | FG-91202 | DNA extraction from agarose gel |
Imager | GE Healthcare | 29083461 | For SDS-PAGE and western blotting |
Imidazole | Wako | 095-00015 | Binding buffer and elution buffer preparation |
Incubator | Nippon Medical & Chemical Instruments | EZ-022 | Temperature setting: 4 °C |
Incubator | Nippon Medical & Chemical Instruments | LH-100-RDS | Temperature setting: 37 °C |
Membrane filter | Merck Millipore | JGWP04700 | 0.2 µm diameter |
Microcentrifuge | Kubota | 3740 | |
NaCl | Wako | 191-01665 | Preparation of binding buffer and elution buffer |
NaH2PO4·2H2O | Wako | 192-02815 | Preparation of binding buffer and elution buffer |
NaOH | Wako | 198-13765 | Preparation of binding buffer and elution buffer |
(NH4)2SO4 | Wako | 015-06737 | Ammonium sulfate precipitation |
Ni-charged resin | Bio-Rad | 1560133 | For IMAC |
PCR primers | Eurofins Genomics | Custom-ordered | |
Protein standard | Bio-Rad | 161-0381 | For SDS-PAGE and western blotting |
Solvent filtration apparatus | As One | FH-1G | |
Spectinomycin | Wako | 195-11531 | Antibiotics; use at 100 μg/mL |
Sterile syringe filter | Merckmillipore | SLGV004SL | 0.22 µm diameter |
Streptococus mutans ΔgtfC | Stock strain in the lab. | gtfC replaced with spcr | |
Streptococus mutans UA159 | Stock strain in the lab. | S. mutans ATCC 700610, Wild-type strain | |
Sucrose | Wako | 196-00015 | For biofilm development |
TAE (50 × ) | Nippon Gene | 313-90035 | For agarose gel electrophoresis |
Thermal cycler | Bio-Rad | PTC-200 | |
Tris-HCl (1 M, pH 8.0) | Wako | 314-90065 | Tris-EDTA buffer preparation |